These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9051718)

  • 1. Protective actions of a thromboxane receptor antagonist, SQ 29548 on the ischemic myocardium: morphologic and hemodynamic effects.
    Singh J; Seth SD; Manchanda SC; Seth S
    Prostaglandins Leukot Essent Fatty Acids; 1997 Feb; 56(2):105-10. PubMed ID: 9051718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the thromboxane receptor antagonist SQ 29,548 on myocardial infarct size in dogs.
    Grover GJ; Schumacher WA
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):29-35. PubMed ID: 2450253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the thromboxane A2 receptor antagonist SQ 29,548 on the severity of pacing-induced ischemia.
    Grover GJ; Schumacher WA
    Basic Res Cardiol; 1989; 84(1):103-10. PubMed ID: 2522297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of thromboxane A2 in reperfusion injury.
    Grover GJ; Sleph PG; Parham C
    Proc Soc Exp Biol Med; 1988 Sep; 188(4):504-8. PubMed ID: 2971219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
    Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
    J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the thromboxane A2/prostaglandin endoperoxide receptor antagonist SQ 30,741 on myocardial infarct size and blood flow during myocardial ischemia and reperfusion.
    Grover GJ; Schumacher WA; Simon M; Parham C
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):701-9. PubMed ID: 2467089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-ischemic actions of a new thromboxane receptor antagonist, SQ-29,548, in acute myocardial ischemia.
    Hock CE; Brezinski ME; Lefer AM
    Eur J Pharmacol; 1986 Mar; 122(2):213-9. PubMed ID: 3011442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of thromboxane A2 in the control of myocardial O2 supply/consumption balance and severity of ischemia during pacing-induced ischemia.
    Grover GJ; Parham CS
    Circ Res; 1989 Mar; 64(3):575-82. PubMed ID: 2917381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial salvage efficacy of a thromboxane receptor antagonist, SQ, 30,741, in relation to inhibition ex vivo of platelet function in the ferret.
    Gomoll AW; Ogletree ML
    Prostaglandins; 1993 Sep; 46(3):233-42. PubMed ID: 8234831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial salvage efficacy of the thromboxane receptor antagonist ifetroban in ferrets and dogs.
    Gomoll AW; Grover GJ; Ogletree ML
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):960-8. PubMed ID: 7898080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective actions of specific thromboxane receptor antagonist in acute myocardial ischemia.
    Brezinski ME; Yanagisawa A; Lefer AM
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):65-71. PubMed ID: 2434797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane receptor antagonist BMS-180291, but not aspirin, reduces the severity of pacing-induced ischemia in dogs.
    Grover GJ; Schumacher WA; Ogletree ML
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):493-9. PubMed ID: 7528306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
    Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT
    J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries.
    Golino P; Buja LM; Ashton JH; Kulkarni P; Taylor A; Willerson JT
    Circulation; 1988 Sep; 78(3):701-11. PubMed ID: 3409505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cardioprotective effects of the thromboxane receptor antagonist SQ 30,741 are not reversed by aspirin.
    Grover GJ; Parham CS; Schumacher WA
    Basic Res Cardiol; 1991; 86(2):99-106. PubMed ID: 1831610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin S2 and thromboxane A2-prostaglandin H2 receptor blockade provide protection against epinephrine-induced cyclic flow variations in severely narrowed canine coronary arteries.
    Ashton JH; Golino P; McNatt JM; Buja LM; Willerson JT
    J Am Coll Cardiol; 1989 Mar; 13(3):755-63. PubMed ID: 2521875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced myocardial neutrophil accumulation and infarct size following thromboxane synthetase inhibitor or receptor antagonist.
    Nichols WW; Mehta J; Wargovich TJ; Franzini D; Lawson D
    Angiology; 1989 Mar; 40(3):209-21. PubMed ID: 2537051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of isoprostanes (8-iso-prostaglandin F2alpha and E2) in isolated guinea pig hearts.
    Möbert J; Becker BF; Zahler S; Gerlach E
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):789-94. PubMed ID: 9234660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat.
    Valentin JP; Bessac AM; Maffre M; John GW
    Eur J Pharmacol; 1996 Dec; 317(2-3):335-42. PubMed ID: 8997619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserve.
    Grover GJ; Schumacher WA
    J Pharmacol Exp Ther; 1989 Feb; 248(2):484-91. PubMed ID: 2521899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.